Join to apply for the Director, Center for Outcomes Research, Real World Evidence and Epidemiology role at Genmab .
At Genmab, we are dedicated to building extraordinary futures, together, by developing antibody products and groundbreaking, knock-your-socks-off KYSO antibody medicines that change lives and the future of cancer treatment and serious diseases. We strive to create, champion and maintain a global workplace where individuals’ unique contributions are valued and drive innovative solutions to meet the needs of our patients, care partners, families and employees. Our people are compassionate, candid, and purposeful, and our business is innovative and rooted in science. We believe that being proudly authentic and determined to be our best is essential to fulfilling our purpose. Yes, our work is incredibly serious and impactful, but we have big ambitions, bring a ton of care to pursuing them, and have a lot of fun while doing so. Does this inspire you and feel like a fit? Then we would love to have you join us!
This position will be responsible for developing and executing HTA strategy in partnership with Market Access. This role requires strong scientific leadership, knowledge of HTA processes, cross‑functional influence, and external engagement experience with HTA processes/ agencies. As part of a growing group, this role will also be in a unique position to deliver locally and contribute to global strategy while helping shape the build of the function in Europe as the company grows. This position can be filled in the UK, France, Germany, Italy, Spain, Netherlands or Denmark.
Genmab maximizes the efficiency of an agile working environment, when possible, for the betterment of employee work‑life balance. Our offices are crafted as open, community‑based spaces that work to connect employees while being immersed in our powerful laboratories. Whether you’re in one of our office spaces or working remotely, we thrive on connecting with each other to innovate.
Genmab is an international biotechnology company with a core purpose to improve the lives of patients through innovative and differentiated antibody therapeutics. For 25 years, its hard‑working, innovative and collaborative team has invented next‑generation antibody technology platforms and harnessed translational, quantitative and data sciences, resulting in a proprietary pipeline including bispecific T‑cell engagers, antibody‑drug conjugates, next‑generation immune checkpoint modulators and effector function‑enhanced antibodies. By 2030, Genmab’s vision is to transform the lives of people with cancer and other serious diseases with Knock‑Your‑Socks‑Off (KYSO) antibody medicines.
#J-18808-LjbffrTyp:
VollzeitArbeitsmodell:
Vor OrtKategorie:
Erfahrung:
2+ yearsArbeitsverhältnis:
AngestelltVeröffentlichungsdatum:
06 Nov 2025Standort:
WorkFromHome
Möchtest über ähnliche Jobs informiert werden? Dann beauftrage jetzt den Fuchsjobs KI Suchagenten!


